Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety
- 31 July 2006
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 51 (1) , 141-145
- https://doi.org/10.1016/j.neuropharm.2006.03.009
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled TrialsCNS Spectrums, 2002
- Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitorsEuropean Neuropsychopharmacology, 2001
- The 5-HTlA receptor agonist flesinoxan increases aversion in a model of panic-like anxiety in ratsJournal of Psychopharmacology, 1999
- Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in ratsEuropean Neuropsychopharmacology, 1998
- Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: Elements of face and predictive validityPsychiatry Research, 1995
- Role of the amygdala and periaqueductal gray in anxiety and panicBehavioural Brain Research, 1993
- Valproate treatment of panic disorder and lactate-induced panic attacksBiological Psychiatry, 1993
- The pharmacological effect of citalopram resides in the (S)-(+)-enantiomerJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- The effect of antidepressants on aversive periaqueductal gray stimulation in ratsEuropean Journal of Pharmacology, 1990
- Effects of serotonin receptor antagonists on PAG stimulation induced aversion: different contributions of 5HT1, 5HT2 and 5HT3 receptorsPsychopharmacology, 1989